Click HERE to register
Over the past couple of decades, insulin prices have risen more than 1000%. These increases have not been due to rising manufacturing costs or expenditures on research and development. Instead, these increases are the result of a complex pricing scheme that has caused significant financial hardship to public entities that are responsible for paying for many of these insulin prescriptions.
Please join us for a detailed discussion of the insulin pricing scheme, the causes of action that can be brought to address it, and the types of clients that are best suited to bring these claims, among other important topics.